Catalan startup Manina Medtech secures €1.75 million in funding to support the efficacy of IVF embryo implantation.
With the help of a sensor built into the transfer catheter, the company has created SEEDCHRONY, a device that allows an AI to instantly assess the uterine environment for embryo implantation.
Read also – London-based Olsam Group Acquired Dwarfs
This implies that the transfer can take place at the optimal time for success, raising the currently low birth rates associated with this kind of treatment to over 30%.
Leading the funding round was Medex Partners, with support from the Ministerio de Ciencia e Innovación via its national scientific research and transfer programme, as well as investments from a group of business angels.
Read also – GLORY to Acquire Flooid
The money will go towards building up SEEDCHRONY’s technological infrastructure, expanding the team, conducting in-depth clinical research, and validating the program’s efficacy.
About Manina Medtech
Manina Medtech increase the success rates of Embryo Transfers, resulting in quicker, healthier, and more economical IVF treatments. Innovative technology to non-invasively and painlessly assess uterine readiness at embryo transfer without interfering with the patient’s journey. Physician assistance with decision-making: When the chances of implantation are highest, Seedchrony advises transferring embryos.